These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Binding of warfarin, salicylate, and diazepam to genetic variants of human serum albumin with known mutations. Kragh-Hansen U, Brennan SO, Galliano M, Sugita O. Mol Pharmacol; 1990 Feb; 37(2):238-42. PubMed ID: 2304452 [Abstract] [Full Text] [Related]
23. Fluorimetric analysis of the binding of warfarin to human serum albumin. Equilibrium and kinetic study. Maes V, Engelborghs Y, Hoebeke J, Maras Y, Vercruysse A. Mol Pharmacol; 1982 Jan; 21(1):100-7. PubMed ID: 7132952 [Abstract] [Full Text] [Related]
29. Effects of nonenzymatic glycation and fatty acids on functional properties of human albumin. Lautenslager GT, Shearman CW, Hud E, Cohen MP. Metabolism; 2011 Dec; 60(12):1683-91. PubMed ID: 21632076 [Abstract] [Full Text] [Related]
30. The binding of sodium warfarin to plasma albumin and its displacement by phenylbutazone. O'Reilly RA. Ann N Y Acad Sci; 1973 Nov 26; 226():293-308. PubMed ID: 4520398 [No Abstract] [Full Text] [Related]
31. Perfluorochemical emulsion effect on warfarin binding by fraction V human albumin. Parsons DL. Arch Int Pharmacodyn Ther; 1987 Mar 26; 286(1):23-30. PubMed ID: 3592858 [Abstract] [Full Text] [Related]
32. Cefazolin serum protein binding and its inhibition by bilirubin, fatty acids and other drugs. Decroix MO, Zini R, Chaumeil JC, Tillement JP. Biochem Pharmacol; 1988 Jul 15; 37(14):2807-14. PubMed ID: 3395358 [Abstract] [Full Text] [Related]
33. Warfarin binding to plasma albumin, measured in patients and related to fatty acid concentrations. Larsen FG, Larsen CG, Andersen S, Nørgaard A, Hansen HE, Brodersen R. Eur J Clin Invest; 1986 Feb 15; 16(1):22-7. PubMed ID: 3084268 [Abstract] [Full Text] [Related]
34. The fatty-acid-induced conformational states of human serum albumin investigated by means of multiple co-binding of protons and oleic acid. Dröge JH, Janssen LH, Wilting J. Biochem J; 1988 Mar 01; 250(2):443-6. PubMed ID: 2833243 [Abstract] [Full Text] [Related]
35. The effects of N-B transition of human serum albumin on the specific drug-binding sites. Wanwimolruk S, Birkett DJ. Biochim Biophys Acta; 1982 Dec 20; 709(2):247-55. PubMed ID: 6185151 [Abstract] [Full Text] [Related]
39. A study on the allosteric interaction between the major binding sites of human serum albumin using microcalorimetry. Dröge JH, Janssen LH, Wilting J. Biochim Biophys Acta; 1985 Mar 01; 827(3):396-402. PubMed ID: 3970944 [Abstract] [Full Text] [Related]
40. Binding of indomethacin to human serum albumin. Its non displacement by various agents, influence of free fatty acids and the unexpected effect of indomethacin on warfarin binding. Zini R, D'Athis P, Barre J, Tillement JP. Biochem Pharmacol; 1979 Sep 01; 28(17):2661-5. PubMed ID: 518678 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]